Compounds > vidarabine
Page last updated: 2024-08-22

vidarabine and Heart Failure

vidarabine has been researched along with Heart Failure in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (30.00)29.6817
2010's7 (70.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Albrecht-Küpper, B; Bräunig, JH; Seifert, R1
Seifert, R2
Ando, K; Cao, X; Izumi-Nakaseko, H; Nakamura, Y; Nakazato, Y; Ohara, H; Sugiyama, A; Wada, T1
Cai, W; Fujita, T; Hidaka, Y; Ishikawa, Y; Kishimura, M; Nakamura, T; Suita, K; Uechi, M; Umemura, M; Yokoyama, U1
Abidi, MH; Braun, TM; Ibrahim, RB; Khaled, YA; Krijanovski, OI; Levine, JE; Mineishi, S; Peres, E1
Sosnowski, M; Trusz-Gluza, M; Wita, K; Wróbel, W1
Baljinnyam, E; Bravo, C; Gao, S; Ishikawa, Y; Iwatsubo, K; Iwatsubo, M; Lai, L; Nakamura, T; Okumura, S; Park, M; Qiu, H; Uechi, M; Umemura, M; Vatner, DE; Vatner, SF; Yan, L; Zhao, X1
Licht, A; Meier, R; Taverna, C; Trojan, A1
Bacigalupo, A; Endo, T; Fujimoto, K; Koike, T; Nakao, S; Nishio, M; Sakai, T; Sawada, K; Takashima, H1

Reviews

1 review(s) available for vidarabine and Heart Failure

ArticleYear
Vidarabine is neither a potent nor a selective AC5 inhibitor.
    Biochemical pharmacology, 2014, Feb-15, Volume: 87, Issue:4

    Topics: Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Animals; Antiviral Agents; Heart Failure; Humans; Isoenzymes; Neoplasms; Vidarabine

2014

Other Studies

9 other study(ies) available for vidarabine and Heart Failure

ArticleYear
Adenylyl cyclase regulation in heart failure due to myocardial infarction in rats.
    Naunyn-Schmiedeberg's archives of pharmacology, 2014, Volume: 387, Issue:4

    Topics: Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Animals; Blood Pressure; Heart Failure; Heart Rate; Heart Ventricles; Isoenzymes; Male; Myocardial Infarction; Nucleotides; Rats; Rats, Wistar; Ventricular Function; Vidarabine

2014
Antiviral drug vidarabine possessing cardiac type 5 adenylyl cyclase inhibitory property did not affect cardiohemodynamic or electrophysiological variables in the halothane-anesthetized dogs.
    The Journal of toxicological sciences, 2016, Volume: 41, Issue:1

    Topics: Adenylyl Cyclase Inhibitors; Anesthesia, Inhalation; Animals; Antiviral Agents; Atrial Fibrillation; Dogs; Electrophysiological Phenomena; Halothane; Heart Failure; Hemodynamics; Infusions, Intravenous; Male; Models, Animal; Vidarabine

2016
Does Vidarabine Mediate Cardioprotection via Inhibition of AC5?
    The Journal of pharmacology and experimental therapeutics, 2016, Volume: 358, Issue:2

    Topics: Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Heart Failure; Humans; Vidarabine

2016
Vidarabine, an Anti-Herpes Virus Agent, Protects Against the Development of Heart Failure With Relatively Mild Side-Effects on Cardiac Function in a Canine Model of Pacing-Induced Dilated Cardiomyopathy.
    Circulation journal : official journal of the Japanese Circulation Society, 2016, Nov-25, Volume: 80, Issue:12

    Topics: Animals; Antiviral Agents; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Disease Models, Animal; Dogs; Female; Heart Failure; Herpesviridae; Humans; Propanolamines; Vidarabine

2016
Cardiac complications in patients undergoing a reduced-intensity conditioning hematopoietic stem cell transplantation.
    Bone marrow transplantation, 2010, Volume: 45, Issue:1

    Topics: Adult; Aged; Anthracyclines; Arrhythmias, Cardiac; Busulfan; Female; Heart Diseases; Heart Failure; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Myocardial Infarction; Risk Factors; Transplantation Conditioning; Vidarabine; Whole-Body Irradiation

2010
Diagnosis by sheer coincidence.
    The international journal of cardiovascular imaging, 2009, Volume: 25, Issue:7

    Topics: Aged; Antineoplastic Agents; Diuretics; Echocardiography, Doppler; Female; Heart Failure; Hodgkin Disease; Humans; Incidental Findings; Pulmonary Subvalvular Stenosis; Tomography, X-Ray Computed; Transposition of Great Vessels; Vidarabine

2009
Prevention of heart failure in mice by an antiviral agent that inhibits type 5 cardiac adenylyl cyclase.
    American journal of physiology. Heart and circulatory physiology, 2012, Jun-15, Volume: 302, Issue:12

    Topics: Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Animals; Antiviral Agents; Extracellular Signal-Regulated MAP Kinases; Heart; Heart Failure; Male; MAP Kinase Signaling System; Mice; Mice, Transgenic; Myocardium; Vidarabine

2012
Eosinophilic pneumonia after administration of fludarabine for the treatment of non-Hodgkin's lymphoma.
    Annals of hematology, 2002, Volume: 81, Issue:9

    Topics: Antineoplastic Agents; Aortic Valve Stenosis; Female; Heart Failure; Humans; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Middle Aged; Pulmonary Eosinophilia; Vidarabine

2002
Successful non-myeloablative stem cell transplantation for a heavily transfused woman with severe aplastic anemia complicated by heart failure.
    Bone marrow transplantation, 2001, Volume: 28, Issue:8

    Topics: Adult; Anabolic Agents; Anemia, Aplastic; Antilymphocyte Serum; Combined Modality Therapy; Cyclosporine; Diabetes Complications; Female; Heart Failure; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Iron Overload; Methylprednisolone; T-Lymphocytes; Transfusion Reaction; Transplantation Conditioning; Transplantation, Homologous; Vidarabine

2001